Steve Mandel's BSX Position Overview
Steve Mandel (via Lone Pine Capital LLC) currently holds 201,703 shares of Boston Scientific Corporation (BSX) worth $19.23 M, representing 0.14% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steve Mandel has initiated a new position in BSX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steve Mandel's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Steve Mandel
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +201,703 | New Buy | 201,703 | $95.35 |
Steve Mandel's Boston Scientific Corporation Investment FAQs
Steve Mandel first purchased Boston Scientific Corporation (BSX) in Q4 2025, acquiring 201,703 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steve Mandel has held Boston Scientific Corporation (BSX) for 1 quarters since Q4 2025.
Steve Mandel's largest addition to Boston Scientific Corporation (BSX) was in Q4 2025, adding 201,703 shares worth $19.23 M.
According to the latest 13F filing for Q4 2025, Steve Mandel's firm, Lone Pine Capital LLC, owns 201,703 shares of Boston Scientific Corporation (BSX), valued at approximately $19.23 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.14% of Steve Mandel's publicly disclosed stock portfolio, making it one of their key holdings.
Steve Mandel's peak holding in Boston Scientific Corporation (BSX) was 201,703 shares, as reported at the end of Q4 2025.